Major adverse cardiac events and drug-coated balloon size in coronary interventions

OBJECTIVE: In-stent restenosis (ISR) is a feared complication after coronary stent implantation. Drug-coated balloon (DCB) is being promoted as a treatment option for ISR. However, the benefit-risk ratio of DCB length has not been investigated. Longer DCBs release more anti-proliferative drug to the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Anatol J Cardiol
Главные авторы: Naguib, David, Knoop, Betül, Dannenberg, Lisa, Liebsch, Eva, Pöhl, Martin, Helten, Carolin, Assadi-Schmidt, Athena, Kelm, Malte, Zeus, Tobias, Polzin, Amin
Формат: Artigo
Язык:Inglês
Опубликовано: Kare Publishing 2018
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5998862/
https://ncbi.nlm.nih.gov/pubmed/29848922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14744/AnatolJCardiol.2018.67864
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы